Cargando…
Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serolo...
Autores principales: | Harvey, Ruth, Mattiuzzo, Giada, Hassall, Mark, Sieberg, Andrea, Müller, Marcel A., Drosten, Christian, Rigsby, Peter, Oxenford, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759245/ https://www.ncbi.nlm.nih.gov/pubmed/31423969 http://dx.doi.org/10.3201/eid2510.190497 |
Ejemplares similares
-
Comparison of platform technologies for assaying antibody to Ebola virus
por: Wilkinson, Dianna E., et al.
Publicado: (2017) -
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
por: Müller, Marcel A, et al.
Publicado: (2015) -
Serological assays for emerging coronaviruses: Challenges and pitfalls
por: Meyer, Benjamin, et al.
Publicado: (2014) -
Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies
por: Okba, Nisreen M.A., et al.
Publicado: (2020) -
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
por: Reusken, Chantal BEM, et al.
Publicado: (2013)